论文信息 - PHASE I/II STUDY OF UMBRALISIB (TGR‐1202) IN COMBINATION WITH UBLITUXIMAB (TG‐1101) AND PEMBROLIZUMAB IN PATIENTS WITH REL/REF CLL AND RICHTER'S TRANSFORMATION - 字舞流文

PHASE I/II STUDY OF UMBRALISIB (TGR‐1202) IN COMBINATION WITH UBLITUXIMAB (TG‐1101) AND PEMBROLIZUMAB IN PATIENTS WITH REL/REF CLL AND RICHTER'S TRANSFORMATION

A. Zelenetz | E. L. Luning Prak | D. Brander | S. Schuster | A. Mato | M. Shadman | P. Becker | J. Svoboda | S. Nasta | L. Roeker | C. Dorsey | K. Kennard | D. Landsburg | J. Elwell | P. Sportelli | P. Tsao | M. Purdom | H. Miskin | C. King | D. Paskalis | M. Weiss | B. Morrigan | L.M. Sarmasti